View of Cerebral Perfusion in Liver Transplantation (NIRS/Doppler)

February 24, 2026 updated by: Yusuf Ziya ÇOLAK, Inonu University

Comparison of Carotid Doppler Ultrasonography With Cerebral Oximetry in Assessing Cerebral Perfusion in Liver Transplantation Surgery

Investigator's aim in this study is to compare the more accessible and low-cost Carotid Doppler USG measurements, which are relatively more difficult to access, costly, and have technical disadvantages, and to demonstrate their superiority over each other in the evaluation of cerebral perfusion in liver transplantation surgeries, without any invasive intervention to the patient.

Study Overview

Detailed Description

Liver transplant surgeries cause intraoperative problems that are difficult to manage from hemodynamic, respiratory, neurological, hematological, and metabolic perspectives due to the nature of liver failure, which affects many organs and systems. Particularly during the anhepatic period, when the healthy graft is integrated into the recipient's vascular system, clamping of the inferior vena cava, one of the two main veins of the hepatic veins, is often required for its connection. This means that a sudden interruption occurs in the blood volume returning to the heart from the lower part of the body, which constitutes half of the total cardiac output.

Cerebral perfusion is also affected during the anhepatic period, and previous studies have observed impaired cerebral perfusion using cerebral oximetry. However, not every clinic has a cerebral oximetry device, and there are factors that limit its use. Some of these factors include high cost, hyperbilirubinemia, variables that disrupt regional blood flow, diabetes, hypertension, and low hemoglobin.

Ultrasound devices are more commonly available in large clinical centers that perform liver transplant surgeries, even for other purposes. It is possible to evaluate the blood flow to the brain using carotid Doppler ultrasonography. The aim of this study is to measure patients' carotid peak systolic and end-diastolic flow and carotid peak systolic flow variability using carotid Doppler ultrasonography and to compare these measurements with cerebral oximetry measurements.

Translated with DeepL.com (free version)

Study Type

Observational

Enrollment (Actual)

43

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Battalgazi
      • Malatya, Battalgazi, Turkey (Türkiye), 44280
        • Inonu University Turgut Ozal Medical Center.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The study population consists of adult patients aged 18-65 years who underwent elective liver transplantation at Inonu University Turgut Ozal Medical Center. All participants had end-stage liver disease and were monitored intraoperatively for cerebral perfusion using carotid Doppler ultrasonography and near-infrared spectroscopy (NIRS). The study was conducted as a single-center, prospective observational study.

Description

Inclusion Criteria:

  • Adult patients aged 18-65 years scheduled for elective liver transplantation
  • Written informed consent obtained prior to participation

Exclusion Criteria:

  • Fulminant hepatic failure
  • Hepatic encephalopathy
  • Hepatorenal or hepatopulmonary syndrome
  • Pre-existing cerebrovascular disease or carotid stenosis
  • Severe cardiopulmonary comorbidity
  • Refusal to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Adult Patients Undergoing Liver Transplantation
This cohort includes adult patients undergoing elective liver transplantation who were monitored for cerebral perfusion using near-infrared spectroscopy (NIRS) and carotid Doppler ultrasonography.
Non-invasive intraoperative monitoring of cerebral perfusion using NIRS and carotid Doppler.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PSv
Time Frame: During surgery: T0: Preanhepatic phase T1: Anhepatic phase T2: Neohepatic phase
peak systolic velocity (PS) cm/sec)
During surgery: T0: Preanhepatic phase T1: Anhepatic phase T2: Neohepatic phase
rSO₂
Time Frame: During surgery: T0: Preanhepatic phase T1: Anhepatic phase T2: Neohepatic phase
regional cerebral oxygen saturation (%)
During surgery: T0: Preanhepatic phase T1: Anhepatic phase T2: Neohepatic phase

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PPV
Time Frame: During surgery: T0: Preanhepatic phase T1: Anhepatic phase T2: Neohepatic phase
pulse pressure variation (%)
During surgery: T0: Preanhepatic phase T1: Anhepatic phase T2: Neohepatic phase
CI
Time Frame: During surgery: T0: Preanhepatic phase T1: Anhepatic phase T2: Neohepatic phase
cardiac index (L/min/m2)
During surgery: T0: Preanhepatic phase T1: Anhepatic phase T2: Neohepatic phase

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2025

Primary Completion (Estimated)

April 1, 2026

Study Completion (Estimated)

April 15, 2026

Study Registration Dates

First Submitted

November 25, 2025

First Submitted That Met QC Criteria

February 24, 2026

First Posted (Actual)

March 2, 2026

Study Record Updates

Last Update Posted (Actual)

March 2, 2026

Last Update Submitted That Met QC Criteria

February 24, 2026

Last Verified

April 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data (IPD) will not be shared due to ethical restrictions and institutional data protection policies. Only aggregated anonymized results will be available upon reasonable request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Liver Transplantation

Clinical Trials on Carotid Doppler Ultrasonography and Near-Infrared Spectroscopy (NIRS)

Subscribe